MetaVia (MTVA) to Release Quarterly Earnings on Wednesday

MetaVia (NASDAQ:MTVA) will likely be announcing its Q2 2025 earnings results before the market opens on Wednesday, August 13th. Analysts expect the company to announce earnings of ($0.32) per share for the quarter.

MetaVia (NASDAQ:MTVA) last posted its quarterly earnings results on Wednesday, May 14th. The company reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.21. On average, analysts expect MetaVia to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

MetaVia Stock Up 0.6%

MTVA opened at $0.60 on Wednesday. MetaVia has a 1-year low of $0.56 and a 1-year high of $4.32. The company has a fifty day moving average price of $0.68 and a two-hundred day moving average price of $1.11.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on MTVA shares. Maxim Group reduced their price objective on shares of MetaVia from $6.00 to $3.00 and set a “buy” rating for the company in a report on Monday, May 19th. HC Wainwright reiterated a “buy” rating and set a $12.00 price objective on shares of MetaVia in a report on Wednesday, April 16th.

MetaVia Company Profile

MetaVia Inc is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc, formerly known as NeuroBo Pharmaceuticals Inc, is based in CAMBRIDGE, Mass.